Minnesota device maker NeoChord won CE Mark approval in the European Union for its DS1000 Mitral Valve Repair system, the company announced this week.
The device allows the implantation of artificial chordae tendinae, thread-like tissues that anchor the leaflets of the mitral valve to heart muscle. Surgeons can use the device to repair mitral valve prolapse via a transapical, off-pump procedure, according to the company.